Tongjitang Chinese Medicines Financial Statements
Tongjitang Chinese Medicines Financial Information
| Company Type | Public |
|---|---|
| Fiscal Year-End | December |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Tongjitang Chinese Medicines Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 81.7 | 62.2 | 42.9 |
| Gross Profit ($ mil.) | 53.5 | 41.4 | 25.3 |
| Operating Income ($ mil.) | 16.6 | 19.2 | 14.2 |
| Total Net Income ($ mil.) | 23.5 | 17.2 | 13.7 |
| Diluted EPS (Net Income) | -- | -- | -- |
Tongjitang Chinese Medicines Stock Quote & Chart
10/10/08 14:59:14 EST •
NYSE •
2.20
•
 0.0000
•
0.0000 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Tongjitang Chinese Medicines Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 6.92 | 3.44 | 1.55 |
| Price/Earnings Ratio | -- | 15.44 | 15.69 |
| Price/Book Ratio | 3.34 | 2.92 | 1.50 |
| Price/Cash Flow Ratio | 177.13 | 12.54 | 9.64 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Tongjitang Chinese Medicines Financial Ratios
Tongjitang Chinese Medicines Competitive Intelligence
| American Oriental Bioengineering | China National Pharmaceutical | Shanghai Pharmaceutical | |
|---|---|---|---|
| Annual Sales ($ mil.) | 160.5 | 60.7 | 149.4 |
| Employees | -- | 250 | 300 |
| Market Cap ($ mil.) | 629.9 | -- | -- |
Competitive Landscape
